The store will not work correctly when cookies are disabled.
3,3-dimethyl-6-(2-methylpyrimidin-5-yl)-1-(1H-pyrrolo[2,3-c]pyridin-4-yl)indolin-2-one
ID: ALA4212469
PubChem CID: 129104202
Max Phase: Preclinical
Molecular Formula: C22H19N5O
Molecular Weight: 369.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ncc(-c2ccc3c(c2)N(c2cncc4[nH]ccc24)C(=O)C3(C)C)cn1
Standard InChI: InChI=1S/C22H19N5O/c1-13-25-9-15(10-26-13)14-4-5-17-19(8-14)27(21(28)22(17,2)3)20-12-23-11-18-16(20)6-7-24-18/h4-12,24H,1-3H3
Standard InChI Key: GXJMSBHSODGFPG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
6.4096 -1.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4137 -2.1420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1194 -1.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2207 -2.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2196 -3.2257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9276 -3.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9258 -1.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5135 -3.6340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8058 -3.2231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0982 -3.6305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0972 -4.4485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8095 -4.8575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5141 -4.4478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6345 -2.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6393 -3.2257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4237 -3.4755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9037 -2.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7209 -2.8015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4086 -4.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6918 -4.6878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6765 -5.5040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3771 -5.9264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3897 -4.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1065 -4.7115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0904 -5.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8562 -5.7878 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3457 -5.1415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8822 -4.4765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 15 2 0
14 7 2 0
7 4 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
5 8 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 2 1 0
2 14 1 0
17 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 25 1 0
24 19 1 0
16 19 1 0
11 23 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 28 2 0
28 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 369.43 | Molecular Weight (Monoisotopic): 369.1590 | AlogP: 4.28 | #Rotatable Bonds: 2 |
Polar Surface Area: 74.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.66 | CX Basic pKa: 4.77 | CX LogP: 2.88 | CX LogD: 2.88 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.57 | Np Likeness Score: -0.32 |